Author:
Geenen Jill J. J.,Linn Sabine C.,Beijnen Jos H.,Schellens Jan H. M.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference83 articles.
1. World Health Organization. Breast cancer, global health estimates. Geneva: World Health Organization; 2013.
2. Liu M, Li Z, Yang J, Jiang Y, Chen Z, Ali Z, et al. Cell-specific biomarkers and targeted biopharmaceuticals for breast cancer treatment. Cell Prolif. 2016;49(4):409–20.
3. Marusyk A, Polyak K. Tumor heterogeneity: causes and consequences. Biochim Biophys Acta. 2010;1805(1):105–17.
4. Tang Y, Wang Y, Kiani MF, Wang B. Classification, treatment strategy, and associated drug resistance in breast cancer. Clin Breast Cancer. 2016;16(5):335–43.
5. Jia LY, Shanmugam MK, Sethi G, Bishayee A. Potential role of targeted therapies in the treatment of triple-negative breast cancer. Anticancer Drugs. 2016;27(3):147–55.